Novartis posts positive phase III ALIGN data for Vanrafia in IgAN, showing slower kidney decline as it eyes full approval in 2026.

FROM land rows to family feuds, Justice Minister Delroy Chuck says unresolved community conflicts are feeding the nation’s ...

In this analysis of patients with myeloperoxidase-ANCA-positive AAV, all urinary complement C3 fragment levels were elevated significantly compared with healthy controls (P <.01 for all).

New data challenge common beliefs about antihistamines, corticosteroids, and vaccines in chronic urticaria, with practical ...

He calmly acknowledged that it’s now more difficult for Russia to advance its foreign policy goals due to the US’ renewed attempt to dominate the global ...

By Bernard Place EVEN if Jersey succeeds in easing pressure at the margins and restoring a first step into independent living ...

Guggenheim Securities Emerging Outlook: Biotech Summit 2026 February 12, 2026 9:30 AM ESTCompany ParticipantsJohn Butler ...

Redevelopment firms like PREFER Access operate in a specialized segment of the market centered on acquisition, renovation, ...

Under the agreement, SanegeneBio has granted Genentech exclusive worldwide rights to develop and commercialize the undisclosed program.

Researchers are exploring a new generation of biochemical markers that may help clinicians detect myocardial contusion. A frequently overlooked form of heart injury caused by blunt chest trauma, ...

A new federal accountability framework will tie every college program to graduate earnings and job placement. Here's how leaders can stay ahead with AI outcomes intelligence.

Q-CTRL’s Ironstone Opal is delivering reliable GPS backup navigation for the defense and aerospace industry. There are ...